These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19682187)

  • 21. [Possibilities and results of endoscopic hemostasis in peptic ulcer hemorrhage].
    Bode JC
    Bildgebung; 1995 Oct; 62 Suppl 2():16-20. PubMed ID: 8589578
    [No Abstract]   [Full Text] [Related]  

  • 22. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
    Lin HJ; Tsai JJ
    Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial.
    Kim JI; Cheung DY; Cho SH; Park SH; Han JY; Kim JK; Han SW; Choi KY; Chung IS
    Dig Dis Sci; 2007 Dec; 52(12):3371-6. PubMed ID: 17514424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEPTIC ULCER DISEASE.
    Dunlap JJ; Patterson S
    Gastroenterol Nurs; 2019; 42(5):451-454. PubMed ID: 31574075
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
    Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
    Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
    Karasawa H; Miwa T
    Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
    Kromer W; Horbach S; Lühmann R
    Pharmacology; 1999 Aug; 59(2):57-77. PubMed ID: 10450061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of bleeding peptic ulcers with omeprazole.
    Munkel L; French L
    J Fam Pract; 1997 Jul; 45(1):20-1. PubMed ID: 9228906
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medical treatment of hemorrhaging ulcer].
    Lesur G
    Presse Med; 2001 Dec 22-29; 30(39-40 Pt 1):1907-9. PubMed ID: 11819918
    [No Abstract]   [Full Text] [Related]  

  • 32. [Standards for bleeding ulcer in the upper gastrointestinal tract].
    Mössner J; Caca K
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S64-8. PubMed ID: 12817325
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficiency of combined endoscopic hemostasis in patients with peptic ulcer complicated by hemorrhage].
    Lipnitskiĭ EM; Alekberadze AV; Ryzhov GR
    Vestn Ross Akad Med Nauk; 2009; (6):28-32. PubMed ID: 19642545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials.
    Fein F; Weber A; Koch S; Festou N; Dupont-Gossard AC; Cervoni JP; Monnet E; Bardou M; Carbonnel F
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):361-7. PubMed ID: 20169656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study.
    Yüksel I; Ataseven H; Köklü S; Ertuğrul I; Başar O; Odemiş B; Ibiş M; Saşmaz N; Sahin B
    Digestion; 2008; 78(1):39-43. PubMed ID: 18824852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
    Ho KY; Kuan A; Zaño F; Goh KL; Mahachai V; Kim DY; Yoon HM
    J Gastroenterol; 2009; 44(7):697-707. PubMed ID: 19434360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.
    Yen HH; Yang CW; Su WW; Soon MS; Wu SS; Lin HJ
    BMC Gastroenterol; 2012 Jun; 12():66. PubMed ID: 22681960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.